Pfizer Agrees To $345 Million Payout To Resolve EpiPen Pricing Lawsuit
The proposed class action settlement was disclosed in a federal court filing in Kansas City. However, the deal does not resolve claims against Mylan, with a trial scheduled for January 2022.
Despite the settlement, Pfizer has said in a statement that it denies any wrongdoing and believes its actions were appropriate. The litigation follows…
Read More...